242 related articles for article (PubMed ID: 31842393)
1. Ataluren for the Treatment of Usher Syndrome 2A Caused by Nonsense Mutations.
Samanta A; Stingl K; Kohl S; Ries J; Linnert J; Nagel-Wolfrum K
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842393
[TBL] [Abstract][Full Text] [Related]
2. Translational read-through as an alternative approach for ocular gene therapy of retinal dystrophies caused by in-frame nonsense mutations.
Nagel-Wolfrum K; Möller F; Penner I; Wolfrum U
Vis Neurosci; 2014 Sep; 31(4-5):309-16. PubMed ID: 24912600
[TBL] [Abstract][Full Text] [Related]
3. Translational Read-Through Therapy of
Vössing C; Owczarek-Lipska M; Nagel-Wolfrum K; Reiff C; Jüschke C; Neidhardt J
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182541
[TBL] [Abstract][Full Text] [Related]
4. Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms.
Ng MY; Li H; Ghelfi MD; Goldman YE; Cooperman BS
Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33414181
[TBL] [Abstract][Full Text] [Related]
5. Translational Read-Through Drugs (TRIDs) Are Able to Restore Protein Expression and Ciliogenesis in Fibroblasts of Patients with Retinitis Pigmentosa Caused by a Premature Termination Codon in
Beryozkin A; Samanta A; Gopalakrishnan P; Khateb S; Banin E; Sharon D; Nagel-Wolfrum K
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408898
[TBL] [Abstract][Full Text] [Related]
6. Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs).
Campofelice A; Lentini L; Di Leonardo A; Melfi R; Tutone M; Pace A; Pibiri I
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284579
[TBL] [Abstract][Full Text] [Related]
7. PTC124-mediated translational readthrough of a nonsense mutation causing Usher syndrome type 1C.
Goldmann T; Overlack N; Wolfrum U; Nagel-Wolfrum K
Hum Gene Ther; 2011 May; 22(5):537-47. PubMed ID: 21235327
[TBL] [Abstract][Full Text] [Related]
8. Translational readthrough of ciliopathy genes BBS2 and ALMS1 restores protein, ciliogenesis and function in patient fibroblasts.
Eintracht J; Forsythe E; May-Simera H; Moosajee M
EBioMedicine; 2021 Aug; 70():103515. PubMed ID: 34365092
[TBL] [Abstract][Full Text] [Related]
9. Novel compound heterozygous nonsense variants, p.L150* and p.Y3565*, of the USH2A gene in a Chinese pedigree are associated with Usher syndrome type IIA.
Fu J; Cheng J; Zhou Q; Khan MA; Duan C; Peng J; Lv H; Fu J
Mol Med Rep; 2020 Oct; 22(4):3464-3472. PubMed ID: 32945453
[TBL] [Abstract][Full Text] [Related]
10. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.
Pierrache LH; Hartel BP; van Wijk E; Meester-Smoor MA; Cremers FP; de Baere E; de Zaeytijd J; van Schooneveld MJ; Cremers CW; Dagnelie G; Hoyng CB; Bergen AA; Leroy BP; Pennings RJ; van den Born LI; Klaver CC
Ophthalmology; 2016 May; 123(5):1151-60. PubMed ID: 26927203
[TBL] [Abstract][Full Text] [Related]
11. A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation.
Goldmann T; Overlack N; Möller F; Belakhov V; van Wyk M; Baasov T; Wolfrum U; Nagel-Wolfrum K
EMBO Mol Med; 2012 Nov; 4(11):1186-99. PubMed ID: 23027640
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II.
Dreyer B; Brox V; Tranebjaerg L; Rosenberg T; Sadeghi AM; Möller C; Nilssen O
Hum Mutat; 2008 Mar; 29(3):451. PubMed ID: 18273898
[TBL] [Abstract][Full Text] [Related]
13. Novel biallelic USH2A variants in a patient with usher syndrome type IIA- a case report.
Young SL; Stanton CM; Livesey BJ; Marsh JA; Cackett PD
BMC Ophthalmol; 2022 Mar; 22(1):140. PubMed ID: 35346118
[TBL] [Abstract][Full Text] [Related]
14. Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells.
Schwarz N; Carr AJ; Lane A; Moeller F; Chen LL; Aguilà M; Nommiste B; Muthiah MN; Kanuga N; Wolfrum U; Nagel-Wolfrum K; da Cruz L; Coffey PJ; Cheetham ME; Hardcastle AJ
Hum Mol Genet; 2015 Feb; 24(4):972-86. PubMed ID: 25292197
[TBL] [Abstract][Full Text] [Related]
15. In vitro and ex vivo suppression by aminoglycosides of PCDH15 nonsense mutations underlying type 1 Usher syndrome.
Rebibo-Sabbah A; Nudelman I; Ahmed ZM; Baasov T; Ben-Yosef T
Hum Genet; 2007 Nov; 122(3-4):373-81. PubMed ID: 17653769
[TBL] [Abstract][Full Text] [Related]
16. The effect of PTC124 on choroideremia fibroblasts and iPSC-derived RPE raises considerations for therapy.
Torriano S; Erkilic N; Baux D; Cereso N; De Luca V; Meunier I; Moosajee M; Roux AF; Hamel CP; Kalatzis V
Sci Rep; 2018 May; 8(1):8234. PubMed ID: 29844446
[TBL] [Abstract][Full Text] [Related]
17. Clinical aspects of Usher syndrome and the USH2A gene in a cohort of 433 patients.
Blanco-Kelly F; Jaijo T; Aller E; Avila-Fernandez A; López-Molina MI; Giménez A; García-Sandoval B; Millán JM; Ayuso C
JAMA Ophthalmol; 2015 Feb; 133(2):157-64. PubMed ID: 25375654
[TBL] [Abstract][Full Text] [Related]
18. Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis.
Sermet-Gaudelus I; Boeck KD; Casimir GJ; Vermeulen F; Leal T; Mogenet A; Roussel D; Fritsch J; Hanssens L; Hirawat S; Miller NL; Constantine S; Reha A; Ajayi T; Elfring GL; Miller LL
Am J Respir Crit Care Med; 2010 Nov; 182(10):1262-72. PubMed ID: 20622033
[TBL] [Abstract][Full Text] [Related]
19. Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression.
Roy B; Friesen WJ; Tomizawa Y; Leszyk JD; Zhuo J; Johnson B; Dakka J; Trotta CR; Xue X; Mutyam V; Keeling KM; Mobley JA; Rowe SM; Bedwell DM; Welch EM; Jacobson A
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12508-12513. PubMed ID: 27702906
[TBL] [Abstract][Full Text] [Related]
20. Screening for duplications, deletions and a common intronic mutation detects 35% of second mutations in patients with USH2A monoallelic mutations on Sanger sequencing.
Steele-Stallard HB; Le Quesne Stabej P; Lenassi E; Luxon LM; Claustres M; Roux AF; Webster AR; Bitner-Glindzicz M
Orphanet J Rare Dis; 2013 Aug; 8():122. PubMed ID: 23924366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
